Sensitive  	Sensitive  	 JJ	B-NP
immunochemical  	immunochemical  	 JJ	I-NP
approaches  	approaches  	 NNS	I-NP
for  	for  	 IN	O
quantitative  	quantitative  	 JJ	O
( 	( 	 -LRB-	O
FPIA 	FPIA 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
qualitative  	qualitative  	 NNS	O
( 	( 	 -LRB-	O
lateral  	lateral  	 JJ	B-NP
flow  	flow  	 NN	I-NP
tests 	tests 	 NNS	I-NP
)  	)  	 -RRB-	O
determination  	determination  	 NN	B-NP
of  	of  	 IN	I-NP
gentamicin  	gentamicin  	 NN	I-NP
in  	in  	 IN	O
milk  	milk  	 NN	O
Three  	Three  	 CD	O
kinds  	kinds  	 NNS	O
of  	of  	 IN	O
immunoassays  	immunoassays  	 NN	B-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
determination  	determination  	 NN	I-NP
of  	of  	 IN	I-NP
gentamicin  	gentamicin  	 NN	I-NP
in  	in  	 IN	O
milk  	milk  	 NN	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
developed  	developed  	 VBN	O
and  	and  	 CC	O
validated 	validated 	 NN	O
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
a  	a  	 DT	O
fast  	fast  	 JJ	O
and  	and  	 CC	O
easily-performed  	easily-performed  	 JJ	O
fluorescence  	fluorescence  	 JJ	B-NP
polarization  	polarization  	 JJ	I-NP
immunoassay  	immunoassay  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
for  	for  	 IN	O
characterization  	characterization  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
employed  	employed  	 VBN	O
polyclonal  	polyclonal  	 JJ	B-NP
antibody 	antibody 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
calculated  	calculated  	 JJ	O
Kaff  	Kaff  	 NNP	B-NP
were  	were  	 VBD	O
( 	( 	 -LRB-	O
1.9±0.4 	1.9±0.4 	 NNP	O
) 	) 	 -RRB-	O
×10 	×10 	 NNP	O
( 	( 	 -LRB-	O
9 	9 	 CD	O
) 	) 	 -RRB-	O
М 	М 	 NNP	O
( 	( 	 -LRB-	O
-1 	-1 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
( 	( 	 -LRB-	O
6.0±0.2 	6.0±0.2 	 NNP	O
) 	) 	 -RRB-	O
×10 	×10 	 NNP	O
( 	( 	 -LRB-	O
6 	6 	 CD	O
) 	) 	 -RRB-	O
М 	М 	 NNP	O
( 	( 	 -LRB-	O
-1 	-1 	 NNP	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
the  	the  	 DT	O
high-  	high-  	 JJ	O
and  	and  	 CC	O
low-affinity  	low-affinity  	 JJ	B-NP
fractions  	fractions  	 NNS	I-NP
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
assay  	assay  	 NN	B-NP
was  	was  	 VBD	O
characterized  	characterized  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
good  	good  	 JJ	O
sensitivity 	sensitivity 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
limit  	limit  	 NN	O
of  	of  	 IN	O
detection  	detection  	 NNS	O
being  	being  	 VBG	B-NP
5μgkg 	5μgkg 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
-1 	-1 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
.  	.  	 .	O
Two  	Two  	 CD	O
different  	different  	 JJ	O
kinds  	kinds  	 NNS	O
of  	of  	 IN	O
detection  	detection  	 JJ	B-NP
labels 	labels 	 NNS	I-NP
,  	,  	 ,	O
i.e.  	i.e.  	 FW	O
colloidal  	colloidal  	 FW	B-NP
gold  	gold  	 FW	I-NP
( 	( 	 -LRB-	O
CG 	CG 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
quantum  	quantum  	 JJ	B-NP
dots  	dots  	 NNS	I-NP
( 	( 	 -LRB-	O
QDs 	QDs 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
were  	were  	 VBD	O
evaluated  	evaluated  	 VBN	O
for  	for  	 IN	O
use  	use  	 NN	O
in  	in  	 IN	O
lateral-flow  	lateral-flow  	 JJ	B-NP
format  	format  	 NN	I-NP
with  	with  	 IN	O
respect  	respect  	 NN	O
to  	to  	 TO	O
rapid  	rapid  	 JJ	O
visual  	visual  	 JJ	O
on-site  	on-site  	 JJ	B-NP
testing 	testing 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cut-off  	cut-off  	 JJ	O
levels  	levels  	 NNS	O
for  	for  	 IN	O
both  	both  	 DT	O
qualitative  	qualitative  	 JJ	B-NP
formats  	formats  	 NNS	I-NP
were  	were  	 VBD	O
selected  	selected  	 VBN	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
maximum  	maximum  	 JJ	O
level  	level  	 NN	O
for  	for  	 IN	O
gentamicin  	gentamicin  	 NN	B-NP
in  	in  	 IN	O
milk  	milk  	 NN	O
established  	established  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
European  	European  	 NNP	O
Commission 	Commission 	 NNP	O
,  	,  	 ,	O
100μgkg 	100μgkg 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
-1 	-1 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
resulting  	resulting  	 VBG	O
in  	in  	 IN	O
a  	a  	 DT	O
10μgkg 	10μgkg 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
-1 	-1 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
cut-off  	cut-off  	 JJ	O
considering  	considering  	 VBG	B-NP
sample  	sample  	 NN	I-NP
dilution 	dilution 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
intra-laboratory  	intra-laboratory  	 JJ	B-NP
validation  	validation  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
with  	with  	 IN	O
sterilized  	sterilized  	 JJ	O
milk  	milk  	 NN	O
samples  	samples  	 NNS	O
artificially  	artificially  	 RB	O
spiked  	spiked  	 VBN	O
with  	with  	 IN	O
gentamicin  	gentamicin  	 NN	B-NP
at  	at  	 IN	O
concentrations  	concentrations  	 NNS	B-NP
less  	less  	 RBR	O
than 	than 	 IN	O
,  	,  	 ,	O
equal  	equal  	 JJ	O
to 	to 	 TO	O
,  	,  	 ,	O
and  	and  	 CC	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
the  	the  	 DT	O
cut-off  	cut-off  	 JJ	O
level 	level 	 NN	O
.  	.  	 .	O
It  	It  	 PRP	O
was  	was  	 VBD	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
milk  	milk  	 NN	O
products  	products  	 NNS	O
could  	could  	 MD	O
be  	be  	 VB	O
analyzed  	analyzed  	 VBN	O
without  	without  	 IN	O
any  	any  	 DT	O
sample  	sample  	 NN	B-NP
preparation 	preparation 	 NN	I-NP
,  	,  	 ,	O
except  	except  	 IN	O
for  	for  	 IN	O
dilution  	dilution  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
buffer  	buffer  	 NN	B-NP
solution 	solution 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
rates  	rates  	 NNS	O
of  	of  	 IN	O
false-positive  	false-positive  	 JJ	B-NP
and  	and  	 CC	O
false-negative  	false-negative  	 JJ	B-NP
results  	results  	 NNS	I-NP
were  	were  	 VBD	O
below  	below  	 IN	O
5 	5 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
both  	both  	 DT	O
labels 	labels 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
different  	different  	 JJ	O
developed  	developed  	 JJ	O
immunoassays  	immunoassays  	 NN	B-NP
were  	were  	 VBD	O
tested  	tested  	 VBN	O
towards  	towards  	 IN	O
gentamicin  	gentamicin  	 JJ	B-NP
determination  	determination  	 NN	I-NP
in  	in  	 IN	O
artificially-spiked  	artificially-spiked  	 JJ	O
and  	and  	 CC	O
naturally  	naturally  	 RB	O
contaminated  	contaminated  	 VBN	O
milk  	milk  	 NN	O
samples 	samples 	 NNS	O
.  	.  	 .	O
